Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease

NCT00660673 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

262

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Parkinson's Disease

Interventions

DRUG: Levodopa-Carbidopa Intestinal Gel (LCIG)
DEVICE: CADD-Legacy® 1400 ambulatory infusion pump
DEVICE: Percutaneous Endoscopic Gastrostomy with jejunal extension tube (PEG-J)

Sponsor

AbbVie

Collaborators

[object Object]